Interestingly, we found an increased abundance of CD4+ CTL in IPT CSF compared with control and MS patient‐derived CSF (Fig 2A), while 10% of CD4+ T cells in IPT CSF were Tph‐like cells (Fig EV5C and D). The gene discussed is TPH1; the disease is myeloid sarcoma.